4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-282736
Chief Scientific Officer sold 3,000 shares at $20.00 ($60,000)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townson Sharon Chief Scientific Officer | 2026-06-23 | Option exercise 10b5-1 | +3,000 | $6.14 | $18,420 | 70,845 | D |
| Townson Sharon Chief Scientific Officer | 2026-06-23 | Sale 10b5-1 | −3,000 | $20.00 | $60,000 | 67,845 | D |
| Derivatives | |||||||
| Townson Sharon Chief Scientific Officer | 2026-06-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,000 | 203,290 | D | ||
| Open-market sales · 3,000 sh · avg $20.00 · $60,000 | |||||||
Loading xslF345X06/ownership.xml…